Login
From:
Eli Lilly and Company
(Uncensored)
subscribe
Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease | Eli Lilly and Company
https://investor.lilly.com/news-releases/news-release-details/lillys-kisunlatm-donanemab-azbt-approved-fda-treatment-early
links
backlinks
Roast topics
Find topics
Find it!
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
